Stock Events

Stock Events

ARS Pharmaceuticals (SPRY) Q3 2024 Earnings

Aug 6Confirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.16

-0.13

-0.1

-0.07

Details

Expected EPS

-0.110633

Actual EPS

-0.13

Surprise EPS

-0.02

Surprise Percent

-17.51%

Description

⁨ARS Pharmaceuticals⁩ (⁦SPRY⁩) has reported earnings of ⁦-0.13⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.